Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-16-156825

Options or other derivatives

  • Director bought 11,500 shares

From the SEC's structured data for this filing

Trades in this filing

Dyrness Albert D. · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-12-22 Purchase : show line 1 in the form Warrant (Right to Buy) +11,500 $3.00 2021-12-22 11,500 11,500 D
Loading xslF345X03/doc4.xml…